Search

Your search keyword '"Sangrigoli, A."' showing total 181 results

Search Constraints

Start Over You searched for: Author "Sangrigoli, A." Remove constraint Author: "Sangrigoli, A."
181 results on '"Sangrigoli, A."'

Search Results

2. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

3. Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: Recurrent Atrial Arrhythmia Burden

5. Prevalence, timing, and impact of early recurrence of atrial tachyarrhythmias after pulsed field ablation: A secondary analysis of the PULSED AF trial

7. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

8. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

11. Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon: Final Results From STOP AF Post-Approval Study

12. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

13. Thromboangiitis Obliterans

14. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial

15. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

16. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

17. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

19. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

20. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

21. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

22. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

23. Achieving regioselective materials binding using multidomain peptides

24. Randomized prospective evaluation of same-day discharge after cryoballoon ablation of atrial fibrillation: results of the EASY PVI study

26. Recognition of Own-Race and Other-Race Faces by Three-Month-Old Infants

27. Evidence of the Face Inversion Effect in 4-Month-Old Infants

28. Effect of Visual Experience on Face Processing: A Developmental Study of Inversion and Non-Native Effects

30. Sustained quality-of-life improvement post-cryoballoon ablation in patients with paroxysmal atrial fibrillation: Results from the STOP-AF Post-Approval Study

31. High-density Grid Use for Left Lateral Accessory Pathway

32. PO-03-160 IS THERE A FUTURE FOR THE 90-DAY BLANKING PERIOD AFTER PULSED FIELD ABLATION: EARLY RECURRENCES IN THE PULSED AF TRIAL

33. MP-483498-005 TIMING, PREVALENCE, AND IMPACT OF EARLY RECURRENCE OF ATRIAL TACHYARRHYTHMIAS AFTER PULSED FIELD ABLATION: SECONDARY ANALYSIS OF PULSED AF

35. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

36. Abstract 14068: Prospective Evaluation of Same-Day Discharge After Cryoballoon Ablation of AF: Results of the Easy-PVI Study

38. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

40. Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon

42. B-PO04-069 FREEDOM FROM SYMPTOMATIC RECURRENCE POST CRYOBALLOON ABLATION IN PERSISTENT ATRIAL FIBRILLATION: RESULTS FROM THE PROSPECTIVE, MULTICENTER STOP PERSISTENT AF TRIAL

44. Why investing in Africa? The differential role of Chinese government support

45. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial

46. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators

47. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

49. 12 MONTH EFFICACY, SAFETY, SYMPTOMS AND IMPROVED QUALITY OF LIFE POST ARCTIC FRONT ADVANCE CRYOBALLOON ABLATION IN PERSISTENT AF PATIENTS: RESULTS FROM THE GLOBAL PROSPECTIVE MULTICENTER STOP PERSISTENT AF STUDY

Catalog

Books, media, physical & digital resources